These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6323713)
1. Synthesis and pharmacological activity of some 9-substituted delta 8-tetrahydrocannabinol analogues. Robertson LR; Duffley RP; Razdan RK; Martin BR; Harris LS; Dewey WL J Med Chem; 1984 Apr; 27(4):550-2. PubMed ID: 6323713 [TBL] [Abstract][Full Text] [Related]
2. Hashish: synthesis and central nervous system activity of some novel analogues of cannabidiol and oxepin derivatives of delta 9-tetrahydrocannabinol. Jorapur VS; Khalil ZH; Duffley RP; Razdan RK; Martin BR; Harris LS; Dewey WL J Med Chem; 1985 Jun; 28(6):783-7. PubMed ID: 2989518 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted cannabidiol and 11- or 12-substituted delta 8-tetrahydrocannabinol. Compton DR; Little PJ; Martin BR; Gilman JW; Saha JK; Jorapur VS; Sard HP; Razdan RK J Med Chem; 1990 May; 33(5):1437-43. PubMed ID: 2158563 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols. Huffman JW; Miller JR; Liddle J; Yu S; Thomas BF; Wiley JL; Martin BR Bioorg Med Chem; 2003 Apr; 11(7):1397-410. PubMed ID: 12628666 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity. Martin BR; Kallman MJ; Kaempf GF; Harris LS; Dewey WL; Razdan RK Pharmacol Biochem Behav; 1984 Jul; 21(1):61-5. PubMed ID: 6087379 [TBL] [Abstract][Full Text] [Related]
6. Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia. Smith PB; Martin BR Brain Res; 1992 Apr; 578(1-2):8-12. PubMed ID: 1324767 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacology of the isomeric methylheptyl-delta8-tetrahydrocannabinols. Huffman JW; Liddle J; Duncan SG; Yu S; Martin BR; Wiley JL Bioorg Med Chem; 1998 Dec; 6(12):2383-96. PubMed ID: 9925296 [TBL] [Abstract][Full Text] [Related]
8. 3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol. Handrick GR; Duffley RP; Lambert G; Murphy JG; Dalzell HC; Howes JF; Razdan RK; Martin BR; Harris LS; Dewey WL J Med Chem; 1982 Dec; 25(12):1447-50. PubMed ID: 6296389 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of halogenated delta 8-THC analogs. Charalambous A; Lin S; Marciniak G; Banijamali A; Friend FL; Compton DR; Martin BR; Makriyannis A Pharmacol Biochem Behav; 1991 Nov; 40(3):509-12. PubMed ID: 1666915 [TBL] [Abstract][Full Text] [Related]
10. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse. Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological activities in mice of halogenated delta 9-tetrahydrocannabinol derivatives. Usami N; Kobana K; Yoshida H; Kimura T; Watanabe K; Yoshimura H; Yamamoto I Chem Pharm Bull (Tokyo); 1998 Sep; 46(9):1462-7. PubMed ID: 9775440 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol. Compton DR; Prescott WR; Martin BR; Siegel C; Gordon PM; Razdan RK J Med Chem; 1991 Nov; 34(11):3310-6. PubMed ID: 1659638 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol. Yoshimura H; Watanabe K; Oguri K; Fujiwara M; Ueki S J Med Chem; 1978 Oct; 21(10):1079-81. PubMed ID: 569207 [TBL] [Abstract][Full Text] [Related]
14. Structure--activity studies on tetrahydro- and hexahydrocannabinol derivatives. Skinner WA; Rackur G; Uyeno E J Pharm Sci; 1979 Mar; 68(3):330-2. PubMed ID: 423121 [TBL] [Abstract][Full Text] [Related]
16. Variation of the alkyl side chain in delta 8-THC. Huffman JW; Lainton JA; Dai D; Jordan RD; Duncan SG Life Sci; 1995; 56(23-24):2021-4. PubMed ID: 7776827 [TBL] [Abstract][Full Text] [Related]
17. Drugs derived from cannabinoids. 7. Tachycardia and analgesia structure-activity relationships in delta9-tetrahydrocannabinol and some synthetic analogues. Osgood PF; Howes JF; Razdan RK; Pars HG J Med Chem; 1978 Aug; 21(8):809-11. PubMed ID: 691006 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of n-hexyl-homologues of delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in the mouse. Brown NK; Harvey DJ Eur J Drug Metab Pharmacokinet; 1988; 13(3):165-76. PubMed ID: 2853671 [TBL] [Abstract][Full Text] [Related]
19. Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs. Little PJ; Compton DR; Mechoulam R; Martin BR Pharmacol Biochem Behav; 1989 Mar; 32(3):661-6. PubMed ID: 2544901 [TBL] [Abstract][Full Text] [Related]
20. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors. Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]